Opportunity for significant reduction in risk of major adverse cardiac events with screening for cardiovascular disease risk factors in hidradenitis suppurativa

Clin Exp Dermatol. 2023 Sep 19;48(10):1175-1177. doi: 10.1093/ced/llad205.

Authors

Niamh Kearney^{1

2

3}, Rosalind Hughes^{1

2

4}, Collette McCourt³, Donal O'Kane³, Brian Kirby^{1

2

4}

Affiliations

¹ Department of Dermatology, St Vincent's University Hospital Dublin, Dublin, Ireland.
² School of Medicine, University College Dublin, Dublin, Ireland.
³ Department of Dermatology, Belfast Health and Social Care Trust, Belfast, Northern Ireland.
⁴ Charles Institute of Dermatology, University College Dublin, Dublin, Ireland.

PMID: 37309914
DOI: 10.1093/ced/llad205

No abstract available

MeSH terms

Cardiovascular Diseases* / diagnosis
Cardiovascular Diseases* / etiology
Heart Disease Risk Factors
Hidradenitis Suppurativa* / complications
Hidradenitis Suppurativa* / diagnosis
Humans